ClinicalTrials.gg
CompletedNCT07447999Updated Nov 10, 2026

Multimodal Deep Learning Model for Predicting the Apnea-Hypopnea Index in Obstructive Sleep

An observational study in Obstructive Sleep Apnea (OSA) and Polysomnography, sponsored by Fu Jen Catholic University. Completed at 1 site in Taiwan. Open to participants aged 30 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-11-10.

Sponsored by Fu Jen Catholic University · Observational

How we know

Updated Nov 10, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
150
Ages
30 Years to 75 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 90 studies in Sleep Apnea, Obstructive with a site in Taiwan — 26 open to participants now, 27 under way, 3 of them phase 3. Sleep Apnea, Obstructive · Taiwan.

Enrollment
11th of 32
150 · median 103
Started
2025
with 7 others
Observational
32 of 90
7 open now
Registered
81st of 90
by date
Lead sponsor
3 of 90
Fu Jen Catholic University

Among the 90 studies in Sleep Apnea, Obstructive with a site in Taiwan, this one is the 11th largest by enrollment of the 32 observational ones that give a count, is one of 8 that started in 2025, is one of 32 observational ones, and was the 81st registered.

Sleep Apnea, Obstructive

2,246 studies on the registry are indexed under Sleep Apnea, Obstructive; 476 are open to participants now.

Browse Sleep Apnea, Obstructive studies →

Open to participants now

26 of the 90 studies in Sleep Apnea, Obstructive with a site in Taiwan are open now. Recruiting first, the newest first:

21 more — sign in →

All 26 open studies →

A study can be open while its sites in Taiwan have not opened yet or have stopped. Only those recruiting at a site in Taiwan →

Who these studies take

Of the 317 Sleep Apnea, Obstructive studies recruiting now, 149 (47%) set no upper age limit and 124 (39%) stop at 75 or younger; 53 take children under 18; 66 take healthy volunteers.

This study: 30 Years to 75 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 90 studies in Sleep Apnea, Obstructive with a site in Taiwan, or all of them as a file.
02

Study summary

This study aims to develop a multimodal deep learning model that integrates noninvasive signals to predict the severity of obstructive sleep apnea. By establishing a clinically viable and user-friendly monitoring tool, the study seeks to enhance early screening accessibility and support the development of home-based sleep care systems.

Read the detailed description

Obstructive sleep apnea is a common sleep disorder closely associated with cardiovascular, metabolic, and neuropsychiatric comorbidities. It is characterized by repeated upper airway collapse during sleep, leading to intermittent hypoxia and sleep fragmentation. Although polysomnography remains the diagnostic gold standard for obstructive sleep apnea, its high cost, complexity, and limited accessibility pose challenges for large-scale screening and early identification. Recent advancements in noninvasive sensing technologies-such as electronic stethoscopes, wearable oximeters, and under-mattress pressure sensors-have enabled low-burden physiological monitoring solutions, offering new opportunities for simplified obstructive sleep apnea detection. In this study, synchronized multimodal physiological data will be collected during overnight sleep, including respiratory sounds, continuous saturation measurements, and standard polysomnography waveforms. Signal preprocessing and feature extraction will be performed to ensure data quality and temporal alignment. A deep learning model will be developed using these multimodal signals as inputs. The apnea-hypopnea index will be derived from overnight polysomnography. The model will be trained to estimate apnea-hypopnea index values and classify obstructive sleep apnea severity according to established clinical thresholds.

03

Conditions studied

  • Obstructive Sleep Apnea (OSA)
  • Polysomnography

Keywords

  • obstructive sleep apnea
  • polysomnography
  • ballistocardiography
  • electronic stethoscope
  • oxygen saturation
04

Who can participate

Ages eligible
30 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

patient of Affiliated University Hospital

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age 30-75 years
  • clinically suspected obstructive sleep apnea and scheduled for polysomnography
  • willing and able to provide written

Exclusion criteria

Exclusion Criteria:

  • intolerance to the electronic stethoscope or fingertip pulse oximeter
  • significant structural airway abnormalities
  • arrhythmia
  • neuromuscular disorders
  • pregnancy
  • hospitalization within the past 1 month
  • inability to provide or requiring legal guardian consent
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
150 participants (actual)
Patient registry
No

Interventions

  • Deviceelectronic stethoscope

    digital device amplifying and recording cardiopulmonary sounds

  • Devicefingertip pulse oximeter

    a small device placed on the finger to measure blood oxygen saturation (SpO₂) and pulse rate noninvasively.

  • Devicepressure-sensing mattresses

    using ballistocardiography (BCG) for monitoring respiration and heart rate

06

What researchers measure

Primary outcomes

  1. apnea-hypopnea index, sound waveforms, and the correlation between apnea-hypopnea index and ballistocardiography waveforms

    Time frame: one night

07

Study locations

1 site
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Sep 2025 to primary completion in Aug 2026, 11 months.

Of 258 non-industry observational studies under Sleep Apnea, Obstructive, half reached primary completion within 31 months of starting (the median), counting those still running; a quarter within 16 and three quarters within 63. This study's 11 months is below that.

Counting every sponsor, half of 294 studies reached it within 29 months; a quarter within 14 and three quarters within 63.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 10, 2026: primary completion Jul 2026 → Aug 2026 and completion Jul 2026 → Aug 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 26, 2026
First posted
Mar 4, 2026
StartActual
Sep 5, 2025
Primary completionActual
Aug 17, 2026was Jul 2026
CompletionActual
Aug 17, 2026was Jul 2026
Last update
Nov 10, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 10, 2026
Primary completion
Jul 31, 2026→Aug 17, 2026 (actual)
Nov 10, 2026
Study completion
Jul 31, 2026→Aug 17, 2026 (actual)
Nov 10, 2026
Show all 1 update
  1. Nov 10, 2026
    Recruiting→Completed
    Primary completion Jul 31, 2026→Aug 17, 2026 (now actual)
    Study completion Jul 31, 2026→Aug 17, 2026 (now actual)
    + 2 other changes: contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07447999
Lead sponsor
Fu Jen Catholic University
Responsible party
Ke-Yun, Chao (Assistant Professor, Fu Jen Catholic University) — Principal investigator
First posted
Mar 4, 2026
Start date
Sep 5, 2025
Primary completion
Aug 17, 2026
Completion
Aug 17, 2026
Last update
Nov 10, 2026

Study contacts

Ke-Yun Chao, PhD
principal investigator · Fu Jen Catholic University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion